Alignment Healthcare (NASDAQ:ALHC) Stock Price Up 8.7% – What’s Next?

Alignment Healthcare, Inc. (NASDAQ:ALHC)’s share price traded up 8.7% on Thursday . The company traded as high as $21.42 and last traded at $21.78. Approximately 736,824 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 4,405,751 shares. The stock had previously closed at $20.03.

Alignment Healthcare News Summary

Here are the key news stories impacting Alignment Healthcare this week:

• Negative Sentiment: Multiple plaintiff law firms, including Howard G. Smith, Kaplan Fox, Frank R. Cruz, Kirby McInerney, Hagens Berman, and Block & Leviton, announced investigations into possible securities-law violations and whistleblower allegations involving Alignment Healthcare. Article: Alignment Healthcare, Inc. (ALHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
• Negative Sentiment: Reports that a former executive alleged accounting irregularities and inflated financial results are likely raising investor concerns about the quality of ALHC’s reported numbers and future legal risk. Article: ALHC INVESTOR ALERT: HBSS Launches Investigation into Alignment Healthcare, Inc. (ALHC) Following Whistleblower Allegations of Financial Manipulation
• Neutral Sentiment: Alignment Healthcare said it will report second-quarter 2026 results on July 30, an event that could become a near-term stock catalyst if investors look for clarity on the allegations and business performance. Article: Alignment Healthcare to Announce Second Quarter 2026 Financial Results and Host Conference Call Thursday, July 30, 2026
• Neutral Sentiment: A short-interest update showed zero reported short interest, offering little incremental trading signal for ALHC. Article: Alignment Healthcare, Inc. (ALHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Wall Street Analyst Weigh In

A number of brokerages recently commented on ALHC. Barclays lowered their price target on shares of Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a report on Tuesday, May 26th. Wall Street Zen upgraded Alignment Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Raymond James Financial set a $22.00 price objective on Alignment Healthcare in a research note on Thursday, May 7th. KeyCorp reiterated an “overweight” rating on shares of Alignment Healthcare in a report on Wednesday, June 10th. Finally, UBS Group reissued a “neutral” rating on shares of Alignment Healthcare in a research report on Wednesday. Six analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $24.30.

Alignment Healthcare Stock Down 5.7%

The company has a debt-to-equity ratio of 1.56, a quick ratio of 1.58 and a current ratio of 1.58. The company’s fifty day moving average price is $19.07 and its 200-day moving average price is $19.79. The stock has a market cap of $4.10 billion, a P/E ratio of 220.33, a price-to-earnings-growth ratio of 2.84 and a beta of 1.05.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings results on Thursday, April 30th. The company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.01 by $0.04. Alignment Healthcare had a net margin of 0.47% and a return on equity of 11.50%. The company had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.22 billion. During the same period in the prior year, the firm posted ($0.05) EPS. The firm’s revenue was up 33.3% compared to the same quarter last year. Equities analysts forecast that Alignment Healthcare, Inc. will post 0.2 EPS for the current year.

Insider Transactions at Alignment Healthcare

In related news, President Dawn Christine Maroney sold 30,000 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $19.55, for a total transaction of $586,500.00. Following the completion of the sale, the president directly owned 947,313 shares of the company’s stock, valued at approximately $18,519,969.15. This trade represents a 3.07% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Hyong Kim sold 35,951 shares of the company’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $19.86, for a total value of $713,986.86. Following the completion of the transaction, the insider directly owned 331,750 shares in the company, valued at $6,588,555. This trade represents a 9.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 854,250 shares of company stock valued at $16,396,606. Company insiders own 5.20% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Wellington Management Group LLP lifted its holdings in Alignment Healthcare by 167.3% during the 3rd quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company’s stock valued at $193,516,000 after buying an additional 6,940,277 shares in the last quarter. Bank of New York Mellon Corp increased its position in shares of Alignment Healthcare by 232.5% during the first quarter. Bank of New York Mellon Corp now owns 3,313,110 shares of the company’s stock worth $58,377,000 after acquiring an additional 2,316,777 shares during the period. Invesco Ltd. increased its position in shares of Alignment Healthcare by 122.3% during the second quarter. Invesco Ltd. now owns 4,170,529 shares of the company’s stock worth $58,387,000 after acquiring an additional 2,294,739 shares during the period. Capital World Investors bought a new stake in shares of Alignment Healthcare during the fourth quarter valued at approximately $44,203,000. Finally, Loomis Sayles & Co. L P bought a new stake in shares of Alignment Healthcare during the fourth quarter valued at approximately $44,162,000. 86.19% of the stock is currently owned by institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.